News

Deal Announcements

BioVascular Secures Series C Financing Round

Monday, February 11, 2008 6:09:00 AM PDT | VentureDeal Staff
SAN DIEGO, CA -- Biotechnology company BioVascular, Inc. has announced that it has raised $10.87 million in third round venture capital financing.

BioVascular is a cardiovascular and vascular disease focused company developing novel therapies for people with platelet-mediated disorders.  The company was founded in 2005.

BB Biotech Ventures led the round, which included Merck Capital Ventures and Domain Associates.  The company said it would use the funding proceeds to support the development of its lead candidates saratin and BVI-007.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1